Pemafibrate-based Solutions for Diverse Industries

Publication ID: 24-11857540_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Pemafibrate-based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857540_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857540_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,540.

Summary of the Inventive Concept

The present inventive concept expands the applications of pemafibrate, a salt thereof, or a solvate of any of these, to novel industries and use cases, leveraging its PPARα activity to address pressing problems in agriculture, environmental sustainability, bioremediation, energy, and building management.

Background and Problem Solved

The original patent disclosed pemafibrate dosing regimens for treating dyslipidemia. However, its potential applications were limited to the pharmaceutical industry. The present inventive concept addresses this limitation by exploring pemafibrate's utility in entirely new fields, thereby unlocking its full potential.

Detailed Description of the Inventive Concept

The new inventive concept encompasses four primary applications: (1) agricultural pest control, where pemafibrate is combined with an OATP1B inhibitor to prevent pest infestation; (2) environmental pollutant reduction, where pemafibrate is administered to waste treatment systems to monitor pollutant reduction; (3) bioremediation of contaminated soil, where pemafibrate enhances microorganism-mediated pollutant degradation; and (4) energy efficiency improvement, where pemafibrate is used to optimize energy usage in buildings and enhance solar panel performance.

Novelty and Inventive Step

The new claims introduce unprecedented applications of pemafibrate, deviating significantly from the original patent's focus on dyslipidemia treatment. The inventive step lies in recognizing pemafibrate's PPARα activity as a valuable asset for addressing diverse industrial challenges.

Alternative Embodiments and Variations

Other potential embodiments of the inventive concept could involve pemafibrate-based solutions for water treatment, textile manufacturing, or cosmetics. Additionally, pemafibrate could be combined with other compounds or used in different formulations to enhance its effectiveness in these new applications.

Potential Commercial Applications and Market

The pemafibrate-based solutions have vast commercial potential, targeting industries such as agriculture, environmental sustainability, energy, and construction. The market size for these applications is substantial, with opportunities for partnerships, licensing, and direct sales.

Field of Art

Pharmaceutical and chemical engineering, with expertise in molecular biology, drug repurposing, and industrial applications of bioactive compounds

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in chemistry, pharmacology, or chemical engineering, capable of understanding molecular interactions, exploring alternative applications of known compounds, and recognizing potential cross-industry uses of bioactive molecules

Obviousness Rationale

Given the source patent's disclosure of pemafibrate's PPARα activity and its fundamental molecular properties, a skilled practitioner would recognize the potential for broader applications beyond dyslipidemia treatment. The PTD's proposed variations represent predictable extensions of the compound's known biological interactions, leveraging its established molecular mechanism to address diverse industrial challenges through routine experimentation and interdisciplinary problem-solving.

Obvious Combinations & Variations

Source Patent Element
Pemafibrate's established PPARα activity for metabolic regulation
PTD Variation
Agricultural pest control using pemafibrate with OATP1B inhibitor
Obviousness Reasoning
A PHOSITA would recognize that molecular signaling mechanisms could be leveraged across biological systems, making pest control a predictable application of a compound with known cellular interaction capabilities
Source Patent Element
Pharmaceutical formulation and dosage optimization techniques
PTD Variation
Bioremediation applications using microorganism-pemafibrate interactions
Obviousness Reasoning
Skilled practitioners would understand that a compound's ability to modulate cellular processes could be systematically explored for environmental engineering applications through standard biotechnological approaches
Source Patent Element
Chemical compound's surface interaction properties
PTD Variation
Solar panel efficiency enhancement using pemafibrate thin film
Obviousness Reasoning
A PHOSITA would recognize that molecular compounds with specific surface characteristics could be predictably tested for materials science and energy applications through routine materials engineering techniques
Source Patent Element
Systemic metabolic pathway modulation demonstrated in original patent
PTD Variation
Energy consumption optimization in building management systems
Obviousness Reasoning
Skilled practitioners would understand that a compound demonstrating systemic regulatory capabilities could be logically extended to complex systems management through standard interdisciplinary research methodologies
Source Patent Element
Pharmaceutical compound with broad molecular interaction potential
PTD Variation
Environmental pollutant monitoring and reduction strategies
Obviousness Reasoning
A PHOSITA would recognize that a molecularly active compound could be systematically investigated for environmental monitoring applications through established chemical and biological screening techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857540 disclosing pemafibrate's fundamental molecular properties and PPARα activity, the present publication demonstrates that the claimed variations represent obvious extensions of the prior art through predictable applications of known molecular interaction mechanisms, thereby rendering subsequent claims of novel industrial uses obvious to one of ordinary skill in the art at the time of invention.

Original Patent Information

Patent NumberUS 11,857,540
TitlePemafibrate dosing regimens
Assignee(s)KOWA COMPANY, LTD.